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Abstract
There are numerous quality of life (QOL) scales. Because QOL experts are often partial to their
own scales, researchers need to be able to select scales for themselves. Scales best suited for
longitudinal purposes (clinical trials and audit) have different properties to those suited for cross-
sectional studies (population and correlational studies and clinical use). The reason and logic of
these differences is explained. For longitudinal use, researchers need to consider the relationship
between item set, population and treatment; scales can be short, floor and ceiling effects must be
avoided, and there should be extended response options. For cross-sectional use scales should
have a wide range of items, should be longer, and there are no adverse floor and ceiling effects, and
response options can be simpler to allow a larger set of items.
Introduction
There are numerous quality of life (QOL) instruments
available to researchers, but little guidance for selection
between them [1]. This choice is made more difficult by
the fact that experts are frequently partial to their own
scales [2]. Although researchers may feel daunted by the
need to choose for themselves, this task is surprisingly
straightforward once the rules underlying QOL scale per-
formance are understood. The purpose of this paper is to
explain those rules.
Purpose of scale
The optimum properties of a QOL scale are determined by
the purpose for which it is put, in the same way that the
selection of a surgical instrument is determined by its use.
There is no such thing as a 'best scale' in an absolute sense,
only scales best suited to a particular purpose. Several
years ago, Guyatt, Kirshner and Jaeschke [3] suggested that
QOL scales can be validated in terms of two purposes:
longitudinal comparison and cross-sectional comparison.
Within each of these two types of use, it is possible to
make a further division based on whether the scale is to be
used for research purpose (i.e., infrequently and for a spe-
cific research project) or whether the scale is to be used in
clinical practice (i.e., is used frequently and without the
benefits of research funding).
This paper uses these two classifications (longitudinal ver-
sus cross-sectional and research versus clinical) to exam-
ine the properties of scales which are most suited for the
following purposes
1. Longitudinal comparison in randomised clinical trials
(RCTs).
2. Longitudinal comparison where the quality of provi-
sion of treatment is being audited by health managers
3. Cross-sectional comparison for statistical purposes.
4. Cross-sectional comparison for clinical purposes.
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QOL scales can be used for other purposes, for example
for resource allocation between different diseases, but this
purpose is not covered here.
Longitudinal comparison in RCTs
The purpose of a QOL scale in a RCT is to be able to detect
important changes in the patient's QOL. A good QOL
scale for use in RCTs is therefore one that is good at detect-
ing change. A QOL scale is nothing more than a set of
items. Those items can be likened to a shopping basket of
experiences selected from the supermarket of possible life
experiences. A good longitudinal QOL scale for RCT use is
one containing items measuring all important aspects of
QOL for the population under study and most of these
items are sensitive to change that would be expected from
the treatments studied. Sensitivity will be determined by
three factors: the items themselves, the treatment and the
population.
If the items of a QOL scale are analysed individually in a
clinical trial, it invariably happens that items vary in the
extent to which they demonstrate improvement, with
some items actually showing a small deterioration. By
adopting a cut off point, the item set can be divided for
convenience into two groups – the 'shifting items' which
demonstrate improvement beyond a criterion and the
'non-shifting items' that show no change or a deteriora-
tion in QOL. Sensitivity to change is function of the pro-
portion of shifting and non-shifting items. Thus, a good
longitudinal scale is a scale that has the many shifting
items.
Whether an item is shifting or not depends on several fac-
tors. The most obvious is purely statistical. If a patient
does not report a problem with a particular item, then that
patient can not improve on that item. This fact is particu-
larly important if the majority of patients have mild QOL
impairment. Items where QOL deficits are reported only
by patients with severe morbidity are unlikely to shift in a
population with mild morbidity – there are many cases
where failure to achieve QOL improvement is because a
criterion of sufficient QOL deficit at baseline has not been
employed. Patients with few recorded problems seldom
provide evidence of improvement. On the other hand, if
an item is experienced as a problem by all patients
because it is a characteristic of the disease, then a treat-
ment that cannot achieve a cure is unlikely to remove that
problem. Items exhibiting floor or ceiling effects are poor
shifters – good shifting items tend to be midrange in terms
of frequency of the reported problem where at least half of
the patients note impairment in their baseline response to
the item. Note that floor and ceiling effects are population
dependent. An item may exhibit a floor effect with a mild
sample of patients, because few patients report the prob-
lem, but is a useful item in a severe sample of patients.
Floor and ceilings can be inferred in part from the distri-
bution of responses to an item within a specified popula-
tion, but content also makes a difference. If an item is
irrelevant to members of a population, then there is little
chance it will show improvement in a longitudinal study.
For example, research in asthma [4] suggests that items
relating to sport shift more in younger populations,
whereas those relating to mobility problems shift more in
older populations. This is because older people are more
likely to find sports items irrelevant whereas younger asth-
matics seldom have mobility problems. The relevance of
an item can be highly population specific. If, for instance,
a patient never does gardening because he lives in a high
rise tower block, then an item on whether his disease
adversely affects gardening is unlikely to shift after any
treatment. Similarly items like shovelling snow in the
backyard are not going to shift in populations living in
temperate climates.
One way of improving the relevance of items to a popula-
tion is to individualise either items or the whole scale to
the individual. For example, patients can be asked to
nominate 5 activities affected by their disease and then
use these individualised items for purposes of rating [5].
Individual quality of life scales often have good longitudi-
nal properties, though individualisation can create prob-
lems if when the scale is used for crossectional purposes.
Item relevance becomes particularly important when
comparing disease specific with generic scales. Suppose a
generic scale containing items on pain sensation is used in
an asthma clinical trial. The pain items will not shift, but
they would be expected to shift if the same scale is used in
an arthritis clinical trial. Of course, there will (almost)
always be some items in a generic scale that will shift irre-
spective of the disease, but the proportion of shifting
items will typically (but not invariably) be less than in a
disease specific scale. Consequently there is a general rule
that generic scales are less sensitive to change than are dis-
ease specific scales [6] – and which goes some way to
explaining the explosion in the number of disease specific
scales created over the last 10 years. Generic scales do have
another use in clinical trials – their broader spread of
items makes them more suited to detecting iatrogenic
effects.
An item may be capable of shifting, but not shift because
the treatment does not create that kind of improvement.
For example a treatment for irritable bowel syndrome
(IBS) which reduces diarrhoea will not affect items in the
scale that relate to problems arising from constipation
(e.g., general malaise and bowel discomfort). Items shift
not only as a function of the population, but also as a
function of the treatment used. The selection of a QOL
scale which is likely to have a good proportion of shiftingHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/24
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items therefore involves trying to match between a popu-
lation and item set, taking into account the kind of
improvement that is possible from the treatment.
Because of the need in longitudinally sensitive scales to
include only items that are potentially relevant to the pop-
ulation, the item set can be relatively short. Good longitu-
dinal scales are typically not more than about 30–40
items. However, much fewer items can be used, and the
shortest scale is the one item global QOL scale [7]. Such
short or one item scales can be very sensitive to treatment,
but their downside is that they lack the ability to inform
how QOL is improving [8].
Whether or not an item is capable of shifting is affected by
one other factor: the response scale format. Patients may
be aware of slight improvement but not substantial
improvement. Response scales of up to about 7 points
(e.g., the Likert scale format) tend to be more sensitive to
change than binary response fomats. A potentially good
longitudinal QOL scale is therefore, likely to be quite
short, describing commonly experienced problems rele-
vant to the population to be investigated and have a
multi-response format. The need for a sensitive multi-
response format is particularly relevant where the item
number is low or where there is just one item (i.e., the glo-
bal scale). Single item global scales typically ask patients
to choose between 10 and 100 levels of QOL.
Longitudinal comparison for purposes of audit purpose
It is often useful to have a scale that can assess to what
extent a particular treatment is successful. Such routine
audit allows comparison between different treatment cen-
tres as well demonstrating to cost-conscious administra-
tors that the treatment is beneficial. When used as an
everyday clinical tool for audit purposes, the QOL scale
needs to be short. As indicated above, short scales can be
very sensitive to change. In selecting an audit scale, it is
important that the scale is sensitive to the particular treat-
ment which is being audited. A good audit tool is not only
appropriate for the disease and population, it is also
appropriate for the treatment. For example, the short form
of the Breathing Problems Questionnaire [9] was
designed as a QOL audit scale in pulmonary rehabilita-
tion and consists of items specifically selected on the basis
that they shift after rehabilitation. Treatment specific
scales would not be appropriate for RCTs. For example, an
IBS scale which measured only the QOL deficits of the
diarrhoea component of IBS would not be a good scale in
an RCT, because this captures only part of the total picture
of QOL. When evaluating between to different drugs it is
necessary to know the total picture in terms of QOL
change. However, when a treatment is audited, then it is
appropriate to focus on specifically those aspect of QOL
that the treatment can improve.
Cross-sectional comparison for statistical purposes
A scale used for cross-sectional studies needs to provide
good discrimination between the severity of QOL deficit
between patients. Imagine a QOL scale comprising only
one item with three response options. Use of this item
enables the researcher to categorise patients on only three
levels. Add on another item, and the ability to discrimi-
nate between different categories of patients is increased.
As more and more items are introduced into the scale, the
ability to discriminate between patients becomes yet
greater. This example illustrates a general rule: the ability
to make fine-grained discriminations between the QOL of
different patients increases as the number of items
increases.
It is necessary, in the case of longitudinal sensitivity to
avoid floor and ceiling effects, but quite the reverse occurs
for a scale designed for cross-sectional sensitivity. If a scale
is limited to items which show a QOL deficit in the major-
ity of patients, then these items will not be able to discrim-
inate between patients at the severe end of the scale,
because at the severe end, all patients will consistently
endorse these items. Discrimination occurs only if some
of the severe patients, the very severe patients, endorse the
Table 1: Properties of QOL scales used for longitudinal and cross-sectional comparison
Likely to be a good Longitudinal questionnaire Likely to be a good Cross-sectional questionnaire
Short (typically 1 – 40 items) Long (typically 20 – 100 items)
Multi-response (e.g., 7-response) format item Simple (e.g., binary or tertiary) response format
Limited severity range: Items describe problems common to most patients, or 
only in the population to be studied
Items cover the whole severity range of QOL deficit
No items showing floor or ceiling effects (i.e., items where >70% respond at 
either end of the scale) within target population
Items with floor and ceiling effects should be included
Items must be relevant to most patients Items need not be relevant to all patients
Items irrelevant to the disease should not be included (unless the scale is used 
to test for iatrogenic change)
Items irrelevant to the disease should not be included (unless the 
scale is to be sensitive to co-morbidity)Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/24
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item and the not-so-very-severe ones do not. The same
logic applies at the mild end of the continuum, if all
patients at the mild end report a problem then there will
be no discrimination between mild patients. This example
illustrates another rule: a good cross-sectional scale
should discriminate between patients over the whole of
the severity range, and therefore will include items rele-
vant to all levels of severity. In such a scale, some items
will be endorsed by most patients, and some items will be
endorsed by very few patients. There are no adverse floor
and ceiling effects.
The need to discriminate across the full severity range is
particularly important where the scale is used for correla-
tional analysis. The size of a correlation depends on the
degree of variation of items in either measure, and if range
is attenuated in the questionnaire due to failure to dis-
criminate, then correlations will be reduced. For example,
if respiratory function correlates poorly with QOL in the
case of severe chronic obstructive pulmonary disease
(COPD) patients, it may be that this is caused by lack of
variation in that population of severe patients – i.e., they
all endorse almost all items as being problematic
Generic QOL scales are sometimes used in cross-sectional
studies. Suppose that a generic scale including several
pain items is used to assess QOL in chronic obstructive
pulmonary disease (COPD) patients. Because they are
elderly, it is likely that many patients will have co-morbid-
ity that creates pain. However, this co-morbidity will be
due to musculo-skeletal problems, not to poor lung
function. The pain items will therefore create variation in
the overall score which will not correlate with lung func-
tion. Thus, the generic scale would be a poor choice if the
aim is to correlate QOL with lung function. On the other
hand, the inclusion of the pain items provides a better
characterisation of the total impact of disease in this pop-
ulation, so if the aim is compare the overall deficit of a
patient population then a generic scale would be better.
Generic scales are, like disease specific scales, a conven-
tionally defined shopping basket of deficits from the total
supermarket of life experiences. If a generic QOL scale has
many pain items but few disturbance sleep items, then
other things being equal, asthma will appear to have
poorer QOL deficit compared with arthritis. On the other
hand, if the generic scale has many sleep disturbance
items but no pain items, then asthma patients will, on
average, appear to have better QOL than arthritic patients.
As with longitudinal comparison, the results are always
scale specific.
In the case of scales requiring longitudinal sensitivity it is
helpful to have response options that are sensitive to
change, for example, by having up to 7 response options.
However, the time taken by a patient to complete a 7
response item is longer than that needed for a binary
response item – so that a scale of 20 7-response items will
take far longer to complete than 20 binary-response.
There is therefore a trade-off between the number of items
a patient can reasonably be expected to complete and
response format. Consequently, because a good cross-sec-
tional scale needs to have a large number of items it may
be appropriate to use a simpler, binary response format.
The cost of increased number of items is paid for by the
simpler response format.
Cross-sectional comparison for clinical purposes
It is sometimes useful to have a QOL scale that provides
an overall picture of the patient's QOL and which can
then be used for clinical decision making. The characteris-
tics of a good scale for clinical cross-sectional comparison
are similar to that for cross-sectional comparison for sta-
tistical reasons, but with one important difference. The
content of the items in the scale need to be selected on the
basis that they inform clinical decision making. For exam-
ple, the inconvenience or cost of medicine can have an
impact on a patient's QOL and this may be particularly
relevant for patient management. Other than selecting for
the clinical purpose, the general principle of cross-sec-
tional comparison remains, i.e., a number of items are
needed that provide discrimination between the mild and
most severe patients – or at least that provide discrimina-
tion within the population that is clinically relevant.
However, because of the time and cost constraints of clin-
ical practice, the scale may need to be shorter than one
which can be used in research settings. Where co-morbid-
ity is expected, then a generic scale may be preferable as it
provides a more holistic picture of the patient's QOL def-
icits, but the choice between generic and disease specific is
decided by judgements about the clinical usefulness of
different scales
Psychometric considerations
Authors of QOL scales normally provide psychometric
data, of varying kinds. Factor analysis or item analysis is
used to demonstrate the unidimensionality of a scale or
subscale (i.e., that the items of the scale can be meaning-
fully added to form a single score). The reliability of the
scale is shown through test-retest correlation or internal
consistency (alpha coefficient), and the scale is correlated
with validating criteria such as other QOL tests or morbid-
ity. Although all QOL questionnaires should satisfy cer-
tain minimum criteria, they do not form an essential part
of choosing between scales. For example, a scale that is
more unidimensional in the sense of having higher inter-
item correlations (or higher factor loadings) is not neces-
sarily better for any of the three purposes above. Reliabil-
ity is important to the extent that a correlation with test
can never by higher than its retest reliability, however,
most scales have acceptable levels of reliability above 0.7,Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/24
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and the majority are above 0.9. I have never come across
a QOL scale that is incapable of demonstrating validating
correlations with other QOL scales, such as the SF-36. The
reason is simply that all self-report measures are strongly
correlated with the personality trait of negative affectivity
(e.g., neuroticism, depression, anxiety), and so QOL
scales inter-correlate amongst themselves. In sum, where
scales have adequate psychometric properties, then this
should not be an important factor when selecting between
them, but it may have an influence, for example, where
two scales are very similar but one is more reliable than
the other. Where scales do not have adequate psychomet-
ric properties, then, perhaps, they should not be used.
Data relating to sensitivity to change, to effect size of 
treatment, and cross-sectional comparison
A major use of QOL scales is in clinical trials where sensi-
tivity to longitudinal change is an important attribute.
Authors often present data demonstrating that their scale
is sensitive to change in these circumstances, and the same
data can be used for another purpose, to demonstrate
effect size of a treatment. A longitudinally sensitive scale
should produce a large effect size in a clinical trail. The
effect size in a clinical trial depends on the proportion of
shifting and shifting items in the QOL scale and that pro-
portion depends, for reasons shown above, on the type of
item, the population and treatment. Effect size is always
the consequence of interaction between treatment, scale
and population – it is not a unique feature of a scale. Nei-
ther the scale nor the treatment can be characterised as
showing a particular effect size (i.e., having a particular
sensitivity to change), because each depends on other fac-
tors. Of course, if one compares the effect size of one scale
with another over several different studies, including dif-
ferent treatments and populations, then it is possible to
draw conclusions about how the two scales perform in
general, but comparisons between scales based on only
one or two RCTS are unsafe. The same argument applies
to the inference of the efficacy of a treatment from its
effect size on a QOL scale: the effect size and hence the
apparent treatment efficacy will be affected also by the
population and the scale.
Discussion
The best way to select a QOL questionnaire is examine the
items of the scale carefully, and judge to what extent the
set of items – i.e., the shopping bag of experiences –
matches the requirements of the research that is to be car-
ried out. This selection does not require a QOL expert: it
can be done by anyone with a good understanding of the
disease and the research requirements. A QOL scale
should have adequate psychometric properties, but
beyond that psychometrics seldom plays a crucial role in
selecting between scales. In addition, the statistical prop-
erties and prior performance of the scale can provide addi-
tional information, but it is important not to over
generalise from statistical data. The important factor, in
the case of longitudinal research, is to choose a scale
where items are appropriate for the population and type
of improvement predicted from treatment. In the case of
cross-sectional research, the important factor is to choose
a scale that has a full and varied range of items which
apply to the kind discrimination needed. In the case of
clinical as opposed to research use, one can focus more on
the types of issues that relevant to the clinical setting.
Common differences between good longitudinal and
good cross-sectional scales are shown in Table 1.
When selecting an instrument from those available it may
happen that no one scale is ideal. Under these circum-
stances, the researcher needs to make a clinical judgement
about suitability from those available, compromising
between the various attributes described above. QOL scale
selection is not an exact science because it is often difficult
to predict the performance of a scale in advance. If no
scale is suited for a particular purpose, then researchers
should consider developing a new one, but there are
many currently available [1].
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